ACT News 227.72 08/27/2014 04:24:52 Actavis Inc (ACT)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Actavis Inc (ACT) 227.72 $ACT

Actavis to Present at Morgan Stanley Global Healthcare Conference 2014
PR Newswire - Tue Aug 26, 3:05PM CDT
Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company, today announced that Brenton Saunders, CEO and President of Actavis, will provide an overview and update of the Company's business at the Morgan Stanley Global Healthcare Conference 2014 in New York, NY.

Supernus' Trokendi XR Faces Generic Threat from Actavis - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 22, 3:55PM CDT
Supernus Pharmaceuticals, Inc. (SUPN) has a notice from Actavis (ACT) regarding the latter's ANDA seeking approval for the generic version of Trokendi XR.

Nasdaq Leads Mixed Session; Actavis Extends Gains
at Investor's Business Daily - Fri Aug 22, 12:27PM CDT
The Nasdaq led a quiet session in early afternoon trade Friday as major averages were unfazed by comments from Fed chief Janet Yellen in Jackson Hole, Wyo., about interest rate policy and the state of the job market. The Nasdaq rose 0.3%, while the...

Actavis Up on Positive Phase III Ceftazidime-Avibactam Data - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 21, 3:30PM CDT
Actavis plc's (ACT) shares were up 2.3% with the company announcing positive top-line results from the phase III RECLAIM-1 and -2 studies on ceftazidime-avibactam.

Acquisitions, Clinical Study Results, Dividends, and Technical Updates - Research Reports on Mallinckrodt, Celgene, Actavis, UnitedHealth and Bristol-Myers
PR Newswire - Thu Aug 21, 7:50AM CDT
Today, Analysts Review released its research reports regarding Mallinckrodt PLC (NYSE: MNK), Celgene Corporation (NASDAQ: CELG), Actavis plc (NYSE: ACT), UnitedHealth Group Inc. (NYSE: UNH) and Bristol-Myers Squibb Co. (NYSE: BMY). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5877-100free.

Bases Have Different Looks But Share Many Similarities
at Investor's Business Daily - Tue Aug 19, 4:25PM CDT
Investor's Corner has covered the major chart patterns you need to know to find a great stock on the verge of launching a big move up. The cup with handle, double bottom, ascending base and base on base all differ. Yet these and other bases share...

Depomed Prevails in Gralise® ANDA Litigation Blocking Generic Entry Until 2024
PR Newswire - Tue Aug 19, 10:15AM CDT
Depomed, Inc. (Nasdaq: DEPO) today announced Judge Joel A. Pisano of the U.S. District Court for the District of New Jersey has ruled in favor of Depomed in the company's patent litigation lawsuit against Actavis, Inc. related to Actavis's Abbreviated New Drug Application for generic versions of Depomed's Gralise® (gabapentin) tablets for the management of postherpetic neuralgia.

Actavis Announces Positive Topline Results From The Phase III Program Of Ceftazidime-Avibactam In Patients With Complicated Intra-Abdominal Infections(cIAI)
PR Newswire - Tue Aug 19, 6:24AM CDT
Actavis plc (NYSE: ACT) today confirmed positive topline results from RECLAIM-1 and -2, pivotal Phase III studies evaluating the potential for the investigational antibiotic, ceftazidime-avibactam as a treatment for adult hospitalized patients with complicated intra-abdominal infections.

Synergy Pharma (SGYP) Posts Wider-than-Expected Loss in Q2 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 13, 2:03PM CDT
Synergy Pharma (SGYP) reported second quarter 2014 loss of 28 cents per share, wider than the year-ago loss of 11 cents and the Zacks Consensus Estimate of a loss of 22 cents.

Collaborations, Financial Results, and Technical Updates - Research Reports on Actavis, UnitedHealth, Bristol-Myers Squibb, Celgene and Aetna
PR Newswire - Tue Aug 12, 7:40AM CDT
Today, Analysts Review released its research reports regarding Actavis PLC (NYSE: ACT), UnitedHealth Group Inc. (NYS: UNH), Bristol-Myers Squibb Co. (NYSE: BMY), Celgene Corporation (NASDAQ: CELG) and Aetna Inc. (NYSE: AET). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5652-100free.

Leaders Actavis, Salix Trip Sell Signals
at Investor's Business Daily - Fri Aug 08, 5:37PM CDT
The market is now in a correction, so investors need to start playing defense instead of offense. Instead of thinking about what to buy next, look at your portfolio and see what needs to be sold. Leading stocks can correct 1-1/2 to 2-1/2 times the...

Stocks Muted; Keurig Green Mountain Down After Hours
at Investor's Business Daily - Wed Aug 06, 4:07PM CDT
Stocks finished slightly higher Wednesday, recovering from a lower open. Volume ran lighter than the prior day, according to preliminary data. The Nasdaq and the Dow Jones industrial average rose 0.1% and the S&P 500 was up a smidgen. After the...

Actavis Beats on Q2 Earnings & Revs, Provides 2015 Outlook - Analyst Blog
Arpita Dutt - Zacks Investment Research - Tue Aug 05, 1:00PM CDT
Actavis (ACT) second quarter results were boosted by the inclusion of products from the Warner Chilcott acquisition.

Ironwood Pharmaceuticals Narrows Q2 Loss, Revenues Down - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 05, 10:00AM CDT
Ironwood Pharmaceuticals, Inc. (IRWD) reported a loss of 38 cents per share (excluding a one-time write-down of inventory) in the second quarter of 2014.

Actavis Guidance Disappoints; Akorn Beats And Raises
at Investor's Business Daily - Tue Aug 05, 9:29AM CDT
Specialty drugmakers and IBD 50 stocks Actavis (ACT) and Akorn were headed in opposite directions in the stock market today after the companies reported their second-quarter earnings and updated their guidance. Actavis' earnings rose 70% over the...

Actavis reports 2Q profit
AP - Tue Aug 05, 7:44AM CDT
DUBLIN (AP) — Actavis PLC (ACT) on Tuesday reported a second-quarter profit after posting a loss in the same period a year ago. The company's results beat analysts' expectations.

Why Akorn (AKRX) Stock Is Advancing Today
at The Street - Tue Aug 05, 7:26AM CDT
Shares of Akorn (AKRX) are up after the pharmaceutical company won U.S. antitrust approval to buy specialty prescription drug company VersaPharm.

Actavis Net Revenue Increases 34% to $2.67 Billion in Second Quarter 2014; Non-GAAP EPS Increases 70% to $3.42
PR Newswire - Tue Aug 05, 6:00AM CDT
Actavis plc (NYSE: ACT) today reported net revenue increased 34 percent to $2.67 billion for the second quarter ended June 30, 2014, compared to $1.99 billion in the second quarter 2013. On a non-GAAP basis, diluted earnings per share for the second quarter 2014 increased to $3.42, compared to $2.01 per diluted share in the second quarter 2013. GAAP earnings per diluted share for the second quarter 2014 were $0.28, compared to a GAAP loss per share of $4.27 in the prior year period.

Jim Cramer's Top Stock Picks: ACT AMZN CAH AAPL
at The Street - Tue Aug 05, 5:00AM CDT
Cramer says Actavis is inexpensive and has room to grow while Amazon can begin to rebound soon.

Jim Cramer's 'Mad Money' Recap: Watch Your Back
at The Street - Mon Aug 04, 6:59PM CDT
Forget what the pundits say, the real reason for the market's turmoil remains Russia, Cramer says.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Local Bounti Expands: Acquires CEA Facilities

Updated Category News Views 96

Local Bounti's Strategic Acquisition Move Local Bounti's at it again, shaking up the indoor agriculture scene by snapping up some real estate from Revol Greens. We're talking 30 acres of primo certified-organic greenhouse space across Texas and Minnesota. And they’re picking these babies up right as they’re ready to grow, not like some flashy land grab. Digging into...

Continue Reading
Investors, Portillo's Fraud Claims Demand Your Attention

Updated Category News Views 91

Portillo's Investors Caught in a Tough Spot Ah, Portillo's. You thought those hot dogs were the only spicy thing you're biting into? Try these allegations on for size. Investors are biting back with a securities fraud lawsuit, and the details are saltier than a bucket of fries. The folks who held PTLO shares between September 19, 2023, and May 4, 2026, are in the...

Continue Reading
Cracking Life Insurance Needs: John Dorsa's Insights

Updated Category News Views 137

Life Insurance: A Necessary Puzzle Life’s uncertainties have a way of putting a wrench in our plans, and nothing screams uncertainty like figuring out life insurance. But fret not! HelloNation’s got insights on this financial maze, and they’ve roped in insurance pro John Dorsa from Ridgeland to help out. Calculating Coverage Needs Forget the one-size-fits-all...

Continue Reading
Lear Gears Up for Goldman Sachs Event Spotlight

Updated Category News Views 132

Lear Prepares for the Big Stage in London Autumn leaves and industry insights are falling in full swing as Lear Corporation gets its ducks in a row for the upcoming Goldman Sachs 18th Annual Industrials & Autos Week. Kicking off on December 3, 2026, this gathering in London isn't just another checkbox on their corporate calendar—it's a prime moment in the spotlight....

Continue Reading
Tenax Class Action: Investors Alley Fight for Redress

Updated Category News Views 149

Tenax Therapeutics in Hot Water Over Drug Trial Results Amidst the ever-unpredictable tides of the pharmaceutical industry, here comes a doozy – Tenax Therapeutics, Inc. is neck-deep in a shareholder lawsuit. If you tossed some money at NASDAQ:TENX anytime between November 13, 2023, and August 7, 2026, you might be feeling the sting of regret, and rightly so. What Went...

Continue Reading
Norris Lake's New Kayak Fleet Propels Tourism Efforts

Updated Category News Views 207

Norris Lake Doubles Down on Water Adventures The winds of change are paddling through Norris Dam State Park as they've launched a new fleet of shiny kayaks, hoping to lure more adventure seekers into the heart of Tennessee. These ain't just boats; they're part of a bigger play by local tourism honchos hungry to pump some adrenaline—and dollars—back into the area. A...

Continue Reading
Sabre Unveils AI Travel Tech: A Bold New Frontier

Updated Category News Views 110

Sabre's Game-Changing AI Travel Integration I'm no stranger to bold moves in the travel industry, but what Sabre's rolling out tomorrow might just be the biggest leap we've seen in a while. They're unleashing what's called the first global travel plug-in within Grok Bot, marking a significant shake-up in the travel tech sphere. Too many tech upgrades in this business...

Continue Reading
Ave7® Pioneers AI-Driven Marketplace Evolution

Updated Category News Views 99

AI Reshapes the Agency Paradigm Nobody saw this coming a decade ago, but here we are—AI's taking the wheel, but with humans still riding shotgun. The agency world, particularly the one dealing with e-commerce giants like Amazon, Walmart, and Target, has flipped on its head. Ave7® steps up as the frontrunner, adapting faster than a broker's reflex after a market bell....

Continue Reading
Grupo Supervielle's Q3 2026: Back to Growth Path

Updated Category News Views 66

Mounting Momentum in Loans and Asset Quality Grupo Supervielle, the Argentine financial player, has been tinkering with its gears to navigate the bumpy roads of 2026. In the third quarter, the company reports a gentle uptick in net loans—up 1.3% sequentially. This was particularly felt in September, with loans increasing 3.7%. Holding Their Own Against the Industry...

Continue Reading
Vertiv's 800 VDC Push Gives AI Builders More Choices

Updated Category News Views 48

Electricity is becoming the awkward roommate inside every serious AI buildout, and Vertiv is trying to move it out of the rack before it eats the whole house. The company has expanded its 800 VDC offering beyond the PowerDirect 5000 rack product introduced in May 2026, laying out systems for the rack, the AI compute pod, and the full data hall. For investors following...

Continue Reading

Top 5 Most Recently Viewed Articles

Vancity Achieves Remarkable Q2 Performance Amid Strategic Shift

Updated Category News Views 345

Vancity Reports Strong Financial Performance in Q2 Vancity recently showcased its outstanding financial results for the second quarter, demonstrating impressive growth across various metrics and solidifying its commitment to its members. This performance is part of Vancity's transformative vision to enhance member experience while making significant contributions to local...

Continue Reading
Celebrating Courtney Rollings Latham's Exceptional Contributions

Updated Category News Views 283

Honoring Courtney Rollings Latham, M.Ed, BCBA It brings us great joy to acknowledge Courtney Rollings Latham, M.Ed, BCBA, for achieving the status of a Pinnacle Professional Member in The Inner Circle of Excellence. This recognition showcases her steadfast commitment to enhancing the fields of Behavior Analysis and Special Education. A Passionate Educator and Analyst...

Continue Reading
Savers Value Village, Inc. Reveals Sales Growth and Conference Plans

Updated Category News Views 158

Savers Value Village, Inc. Reports Preliminary Sales Results BELLEVUE, Wash. – Savers Value Village, Inc. (NYSE: SVV) has released its preliminary net sales for the recent quarter along with its full year results for fiscal 2024. This announcement coincides with the Company’s upcoming participation in the ICR Conference scheduled for mid-January 2025. Sales...

Continue Reading
Empowering Salon Professionals Through Natural Disasters Support

Updated Category News Views 241

Empowering Professionals in the Face of Adversity Natural disasters can strike unexpectedly, causing chaos and distress. My Salon Suite®, a franchise dedicated to providing beauty, health, and wellness professionals with personal spaces for their businesses, has been at the forefront of community support during such challenging times. As we navigate through the hurricane...

Continue Reading
Major Revenue Surge: POP Culture Group's Impressive FY2025 Results

Updated Category News Views 201

POP Culture Group Achieves Record Revenue in FY2025 In a remarkable financial breakthrough, POP Culture Group Co., Ltd. (Nasdaq: CPOP) has announced its fiscal year 2025 results, showcasing an incredible revenue surge that exceeded $100 million for the first time. This milestone represents a significant leap, with revenue increasing by 127% compared to the previous fiscal...

Continue Reading